Audited Financial Results for the quarter ended on 31-03-2025

Results View source PDF Explain this filing

INDOUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.4%Reaction day

₹150.00

prior close

₹151.80

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.1%+4.5% vs market

Other Agricultural Products peers, median of 55sector-0.4%+4.8% vs sector

On the reaction day the stock moved 4.5 pts more than Nifty Microcap 250 and 4.8 pts more than its Other Agricultural Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

+1.1

15m

+0.2

30m

+1.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.4-0.1+4.5-0.4+4.8

Next day

+9.6+0.2+9.4+0.0+9.6

+14.7+0.6+14.1-0.7+15.4

+12.9+0.9+12.0-1.8+14.7

+8.6+1.0+7.6-1.9+10.6

+4.1+0.7+3.4-2.0+6.1

+6.3+1.8+4.6-1.3+7.7

15d

+0.7+1.7-1.0-1.7+2.4

+3.2+3.1+0.1-2.6+5.7

+7.6+1.7+5.9-5.5+13.1

+0.0-1.0+1.0-8.9+8.9

UpDownMarket · Nifty Microcap 250Sector · Other Agricultural Products peers, median of 55Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Indo Us Biotech Limited has filed its audited financial results for the quarter and year ended March 31, 2025 on NSE. The actual financial figures, key line items (revenue, profit after tax, EBITDA), and any auditor observations are not included in the provided announcement text, so specific numbers cannot be reported. Based solely on the headline, this is a routine quarterly/annual results disclosure required of listed companies. No detail on auditor's opinion type, exceptional items, related-party transactions, debt levels, or cash flows is available in the supplied content.

Likely market impact

Without the actual numbers or auditor commentary in the filing text, no meaningful impact on shareholders or the stock price can be assessed. Investors should read the full audited results document for revenue, PAT, margins, and any auditor qualifications before drawing conclusions.